![N-(2,2,2-Trifluoroethyl)-9-(4-[4-[4'-(trifluoromethyl)[1,1'-biphenyl]-2-carboxamido]piperidin-1-yl…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FFT103664.webp&w=3840&q=75)

N-(2,2,2-Trifluoroethyl)-9-(4-[4-[4'-(trifluoromethyl)[1,1'-biphenyl]-2-carboxamido]piperidin-1-yl]butyl)-9H-fluorene-9-carboxamide
CAS:
Ref. 3D-FT103664
![N-(2,2,2-Trifluoroethyl)-9-(4-[4-[4'-(trifluoromethyl)[1,1'-biphenyl]-2-carboxamido]piperidin-1-yl…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FFT103664.webp&w=3840&q=75)

Informação sobre produto
Nome:N-(2,2,2-Trifluoroethyl)-9-(4-[4-[4'-(trifluoromethyl)[1,1'-biphenyl]-2-carboxamido]piperidin-1-yl]butyl)-9H-fluorene-9-carboxamide
Marca:Biosynth
Descrição:Lomitapide is a drug that inhibits the enzyme PCSK9, which regulates the amount of low-density lipoprotein (LDL) cholesterol in the blood. It is used to treat people with high LDL cholesterol levels who have already tried other treatments, such as diet and exercise. Lomitapide has been shown to reduce LDL-cholesterol by up to 60% in patients with primary sclerosing cholangitis and metabolic disorders. In clinical trials, lomitapide was well tolerated for up to 2 years of treatment, with side effects such as headache and diarrhea occurring at rates similar to those seen in patients taking placebo.
Aviso:Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Propriedades químicas
Peso molecular:693.72 g/mol
Fórmula:C39H37F6N3O2
Pureza:Min. 95%
InChI:InChI=1S/C39H37F6N3O2/c40-38(41,42)25-46-36(50)37(33-13-5-3-10-30(33)31-11-4-6-14-34(31)37)21-7-8-22-48-23-19-28(20-24-48)47-35(49)32-12-2-1-9-29(32)26-15-17-27(18-16-26)39(43,44)45/h1-6,9-18,28H,7-8,19-25H2,(H,46,50)(H,47,49)
Chave InChI:InChIKey=MBBCVAKAJPKAKM-UHFFFAOYSA-N
SMILES:O=C(NC1CCN(CCCCC2(C(=O)NCC(F)(F)F)c3ccccc3-c3ccccc32)CC1)c1ccccc1-c1ccc(C(F)(F)F)cc1